CN Patent

CN115010639B — 一种中间体化合物及其制备方法和应用

Assigned to Shanghai Aiyang Chemical Technology Co ltd · Expires 2024-03-08 · 2y expired

What this patent protects

本发明涉及有机合成和原料药的制备技术领域，公开了具有式A结构的PF‑07321332的中间体，及制备方法用于制备PF‑07321332的中间体化合物。与现有技术相比，本发明的中间体与化合物缩合反应后可以直接得到目标产物，简化了反应，减少副产物，产品纯度高。

USPTO Abstract

本发明涉及有机合成和原料药的制备技术领域，公开了具有式A结构的PF‑07321332的中间体，及制备方法用于制备PF‑07321332的中间体化合物。与现有技术相比，本发明的中间体与化合物缩合反应后可以直接得到目标产物，简化了反应，减少副产物，产品纯度高。

Drugs covered by this patent

Patent Metadata

Patent number
CN115010639B
Jurisdiction
CN
Classification
—
Expires
2024-03-08
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Aiyang Chemical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.